Product Description: Dideoxycytidinene (2′,3′-Didehydro-2′,3′-dideoxycytidine) is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
Applications: Cancer-programmed cell death
Formula: C9H11N3O3
References: [1]Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88.
CAS Number: 7481-88-1
Molecular Weight: 209.20
Compound Purity: 98.36
Research Area: Cancer
Solubility: 10 mM in DMSO
Target: Nucleoside Antimetabolite/Analog